1Misu T, Takahashi T, Nakashima I, et al, Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis. Rinsho Byori, 2009, 57:262-270.
2Itoyama Y. What I have learned and accomplished through research on multiple sclerosis (MS). Rinsho Shinkeigaku, 2009, 49 : 699 -707.
3Waters P, Vincent A. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica : current status of the assays. Int MS J, 2008, 15.99-105.
4Jarius S, Probst C, Borowski K, et al. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci, 2010, 291:52-56.
5McKeon A, Fryer JP, Apiwattanakul M, et al. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol, 2009, 66 : 1134-1138.
6Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology, 2006, 66 : 1485-1489.
7Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain, 2007, 130.. 1235-1243.
9Saadoun S, Waters P, Bell BA, et al. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain, 2010, 133: 349-361.
10Tradtrantip L, Zhang H, Saadoun S, et al. Anti-aquaporin-4monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol, 2012, 71:314-322.
